Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Liquid biopsy guided precision therapy for lung cancers
    Journal Article

    Xu, C.; Offin, M.; Paik, P. K.; Li, B. T.
    Journal of Thoracic Disease (2018)

    Fulltext@MSK | Save
  • One step forward, two steps back: Trends in aggressive inpatient care at the end of life for patients with stage IV lung cancer
    Journal Article

    Mrad, C.; Abougergi, M. S.; Daly, B.
    Journal of Oncology Practice (2018)

    Fulltext@MSK | Save
  • Clinical utility of prospective molecular characterization in advanced endometrial cancer
    Journal Article

    Soumerai, T. E.; Donoghue, M. T. A.; Bandlamudi, C.; Srinivasan, P.; Chang, M. T.; Zamarin, D.; Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Tew, W. P.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • Integrative molecular characterization of malignant pleural mesothelioma
    Journal Article

    Hmeljak, J.; Sanchez-Vega, F.; Hoadley, K. A.; Shih, J.; Stewart, C.; Heiman, D.; Tarpey, P.; Danilova, L.; Drill, E.; Gibb, E. A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Tumor-agnostic drug development
    Journal Article

    Offin, M.; Liu, D.; Drilon, A.
    American Society of Clinical Oncology Educational Book (2018)

    Fulltext@MSK | Save
  • Ultra-rapid EGFR mutation assessment in lung adenocarcinoma without prior DNA extraction
    Meeting Abstract

    Arcila, M. E.; Salazar, P. A.; Rijo, I.; Elezovic, D.; Rekhtman, N.; Buonocore, D. J.; Lin, O.; Chaft, J. E.; Ladanyi, M.; Nafa, K.
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save
  • Clinical validation of MSK-ACCESS: An ultrasensitive next-generation sequencing assay for liquid biopsies in the clinic
    Meeting Abstract

    Brannon, A.; Jayakumaran, G.; Patel, J.; Johnson, I.; Diosdado, M.; Hasan, M.; Perera, D.; Meng, F.; Jing, X.; Reichel, J.; more...
    Journal of Molecular Diagnostics (2018)

    Fulltext@MSK | Save
  • Genetic predictors of response to chemoradiation in stage III non-small-cell lung cancer
    Meeting Abstract

    Luo, L.; Samstein, R.; Dick-Godfrey, R.; Oro, F.; Sonnick, M.; Paik, P.; Chaft, J.; Rimner, A.; Wu, A. J.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • PARP trapping by talazoparib is a potent mechanism of radiosensitization in small cell lung cancer cell lines and patient-derived xenografts
    Meeting Abstract

    Laird, J. H. Jr; Lok, B. H.; Ma, J.; Bell, A.; De Stanchina, E.; Poirier, J.; Rudin, C. M.
    International Journal of Radiation Oncology, Biology, Physics (2018)

    Fulltext@MSK | Save
  • CheckMate 227: Nivolumab + ipilimumab vs platinum-doublet chemotherapy as first-line treatment for advanced non-small cell lung cancer (NSCLC) with high tumor mutational burden (TMB)
    Meeting Abstract

    Gerber, D. E.; Reck, M.; Hellmann, M. D.; Paz-Ares, L.; Borghaei, H.; Brahmer, J.; O'Byrne, K. J.; Bhagavatheeswaran, P.; Nathan, F.; Ramalingam, S. S.
    Journal of Oncology Navigation & Survivorship (2018)

    Fulltext@MSK | Save